Institute of Biomedical Technology, University of Tampere and BioMediTech, Tampere, Finland.
Genes Chromosomes Cancer. 2013 Dec;52(12):1103-13. doi: 10.1002/gcc.22107. Epub 2013 Sep 2.
In the past 10 years research on miRNAs has demonstrated their central role in regulating gene expression both in normal and diseased tissue. The expression of miRNAs is widely altered in cancer, leading to abnormal expression of the genes regulated by these miRNAs, and subsequently alterations in entire molecular networks and pathways. One especially interesting cancer-related miRNA is miR-31 which is frequently altered in a large variety of cancers. The functional role of miR-31 is extremely complex and miR-31 can hold both tumor suppressive and oncogenic roles in different tumor types. The phenotype caused by aberrant miR-31 expression seems to be strongly dependent on the endogenous expression levels. For example, in breast cancer loss of miR-31 expression is associated with high risk of metastases, whereas in colorectal cancer high miR-31 expression correlates with advanced disease stage. This review summarizes the complex expression patterns of miR-31 in human cancers, describes the variable phenotypes caused by altered miR-31 expression, and highlights the current knowledge on the genes targeted by miR-31.
在过去的 10 年中,对 miRNA 的研究表明它们在正常组织和病变组织中调节基因表达方面发挥着核心作用。miRNA 的表达在癌症中广泛改变,导致这些 miRNA 调控的基因异常表达,进而导致整个分子网络和途径发生改变。miR-31 是一种特别有趣的与癌症相关的 miRNA,它在多种癌症中经常发生改变。miR-31 的功能作用非常复杂,在不同的肿瘤类型中,miR-31 可以发挥肿瘤抑制或致癌作用。异常表达的 miR-31 引起的表型似乎强烈依赖于内源性表达水平。例如,在乳腺癌中,miR-31 表达的缺失与转移的高风险相关,而在结直肠癌中,高 miR-31 表达与晚期疾病阶段相关。本综述总结了 miR-31 在人类癌症中的复杂表达模式,描述了由 miR-31 表达改变引起的不同表型,并强调了目前关于 miR-31 靶向基因的知识。